Results 61 to 70 of about 17,718 (201)
Al-Azhar Assiut Medical Journal, 2019 Background Diabetic macular edema (DME) is a common cause of blindness and visual impairment in diabetic patients, which can affect the quality of life.
Abd El-Magid M Tag El-Din
doaj +1 more source
Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
Clinical Ophthalmology, 2011 Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C, Stem M, Comer GM
doaj
Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.
PLoS ONE, 2014 PurposeIt is known that endothelial cells in the kidney are also strongly VEGF-dependent. Whether intravitreal drugs can be detected within the glomeruli or affect VEGF in glomerular podocytes is not known.
Alexander Tschulakow +5 more
doaj +1 more source
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema [PDF]
, 2023 Ahmed Fathy Gabr +2 more
openalex +1 more source
Ranibizumab for the Treatment of Visual Impairment Due to Myopic Choroidal Neovascularization: Cost-Effectiveness Versus Aflibercept [PDF]
, 2014 Claudia Leteneux +3 more
openalex +1 more source
Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy [PDF]
, 2019 Zhaodong Du +6 more
openalex +1 more source